118 related articles for article (PubMed ID: 17108118)
1. Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism.
Anumanthan G; Halder SK; Friedman DB; Datta PK
Cancer Res; 2006 Nov; 66(22):10824-32. PubMed ID: 17108118
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK
Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of serine-threonine receptor kinase-associated protein in colorectal cancers.
Kim CJ; Choi BJ; Song JH; Park YK; Cho YG; Nam SW; Yoo NJ; Lee JY; Park WS
Pathol Int; 2007 Apr; 57(4):178-82. PubMed ID: 17316412
[TBL] [Abstract][Full Text] [Related]
5. The Ewing's sarcoma gene product functions as a transcriptional activator.
Rossow KL; Janknecht R
Cancer Res; 2001 Mar; 61(6):2690-5. PubMed ID: 11289149
[TBL] [Abstract][Full Text] [Related]
6. The EWS-Oct-4 fusion gene encodes a transforming gene.
Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
[TBL] [Abstract][Full Text] [Related]
7. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
Laflamme C; Filion C; Bridge JA; Ladanyi M; Goldring MB; Labelle Y
Cancer Res; 2003 Jan; 63(2):449-54. PubMed ID: 12543801
[TBL] [Abstract][Full Text] [Related]
8. Dynamic subcellular localization of the Ewing sarcoma proto-oncoprotein and its association with and stabilization of microtubules.
Leemann-Zakaryan RP; Pahlich S; Sedda MJ; Quero L; Grossenbacher D; Gehring H
J Mol Biol; 2009 Feb; 386(1):1-13. PubMed ID: 19133275
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of the nuclear localization/retention signal in the EWS proto-oncoprotein.
Zakaryan RP; Gehring H
J Mol Biol; 2006 Oct; 363(1):27-38. PubMed ID: 16965792
[TBL] [Abstract][Full Text] [Related]
10. TLS, EWS and TAF15: a model for transcriptional integration of gene expression.
Law WJ; Cann KL; Hicks GG
Brief Funct Genomic Proteomic; 2006 Mar; 5(1):8-14. PubMed ID: 16769671
[TBL] [Abstract][Full Text] [Related]
11. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
12. The upregulation of expressed proteins in HepG2 cells transfected by the recombinant plasmid-containing HBx gene.
He Y; Yang F; Wang F; Song SX; Li DA; Guo YJ; Sun SH
Scand J Immunol; 2007 Mar; 65(3):249-56. PubMed ID: 17309779
[TBL] [Abstract][Full Text] [Related]
13. A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Werner H; Idelman G; Rubinstein M; Pattee P; Nagalla SR; Roberts CT
Cancer Lett; 2007 Mar; 247(1):84-90. PubMed ID: 16730884
[TBL] [Abstract][Full Text] [Related]
14. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins.
Guipaud O; Guillonneau F; Labas V; Praseuth D; Rossier J; Lopez B; Bertrand P
Proteomics; 2006 Nov; 6(22):5962-72. PubMed ID: 17106916
[TBL] [Abstract][Full Text] [Related]
15. Subcellular fractionation of TGF-beta1-stimulated lung epithelial cells: a novel proteomic approach for identifying signaling intermediates.
Milosevic J; Bulau P; Mortz E; Eickelberg O
Proteomics; 2009 Mar; 9(5):1230-40. PubMed ID: 19253281
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of serine-threonine kinase receptor-associated protein in patients with systemic lupus erythematosus.
Wang L; Dai Y; Peng W; Qi S; Ouyang X; Tu Z
Lupus; 2011 Aug; 20(9):921-7. PubMed ID: 21613329
[TBL] [Abstract][Full Text] [Related]
17. EWS differentially activates transcription of the Brn-3a long and short isoform mRNAs from distinct promoters.
Thomas GR; Faulkes DJ; Gascoyne D; Latchman DS
Biochem Biophys Res Commun; 2004 Jun; 318(4):1045-51. PubMed ID: 15147979
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
20. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
